The sample copy of this report is available for access.
“Global Spirometer Market to reach a market value of USD 1,511.6 Million by 2033 growing at a CAGR of 7.9%”
The Global Spirometer Market is expected to reach USD 1511.6 million by 2033, growing at a CAGR of 7.9% during (2026 - 2033).
Spirometer market is estimated to experience significant growth because of surging demand for pulmonary function assessment, respiratory disease diagnosis, routine pulmonary care, and continuous lung health monitoring across clinics, hospitals, homecare settings, and diagnostic centers. Rising awareness of preventive screening programs, respiratory health, handheld spirometers, portable devices, cloud-based data management, wireless connectivity, and remote monitoring capabilities is further supporting the market expansion. The market emerged from the early need to quantitively assess pulmonary function through devices designed to measure lung volumes.
Spirometer market is experiencing growth as asthma control, chronic respiratory disease management, preventive screening, COPD diagnosis, and pulmonary function assessment become more important across healthcare systems. Digital spirometer are largely being integrated with electronic health records, mobile applications, telemedicine platforms, electronic health records, automated reporting systems, and cloud storage. Connected and portable devices are expanding the use of spirometry beyond hospitals into diagnostic centers, outpatient clinics, occupational health, homecare, diagnostic centers, and remote patient monitoring programs.
Spirometer market is moderately consolidated and tech-driven with competition surged by respiratory diagnostics specialists, diversified medical device firms, and pulmonary function testing companies. Market players are positioning themselves ahead through portability, device accuracy, cloud connectivity, software integration, ease of use, automated quality control, and interoperability with digital health platforms. Market competition further depends on remote monitoring, AI-assisted interpretation, software-enabled workflow integration, and broader adoption across decentralized healthcare settings.
Spirometer market is led by NDD Medical Technologies, Vyaire Medical, and Medical International Research forming the leading competitive tier across primary care, hospital pulmonary laboratories, portable spirometry applications, and clinical research. MGC Diagnostics, Vitalograph, and SCHILLER support the market through clinical trial spirometry, advanced PFT systems, and integrated cardiopulmonary diagnostic platforms. Geratherm Respiratory, COSMED, Ganshorn Medizin Electronic, and Fukuda Sangyo support the competition across regional healthcare markets, and specialized pulmonary diagnostics and research. Market competition relies on AI-assisted interpretation, connected spirometry, remote monitoring, and home-based respiratory assessment.
Based on Type, the market is segmented into Volume Measurement and Peak Flow Meters. The Volume Measurement market dominated the Global Spirometer Market by Type in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 1057.9 million by 2033, growing at a CAGR of 7.6 % during the forecast period. The Peak Flow Meters market is expected to witness a CAGR of 8.5% during (2026 - 2033).
Volume Measurement leads the market due to its extensive use in comprehensive pulmonary function testing across hospitals, pulmonary laboratories, specialty clinics, and diagnostic centers. These systems support detailed assessment of lung volumes, airflow, and respiratory performance, making them important for COPD, asthma, restrictive lung disorders, and other pulmonary conditions. Peak Flow Meters remain important for affordable and convenient respiratory monitoring, particularly in asthma management, outpatient care, home-based tracking, and routine airflow limitation assessment.
Based on Product Type, the market is segmented into Devices, Accessories & Consumables, and Software. The Devices market dominated the Global Spirometer Market by Product Type in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 838.8 million by 2033, growing at a CAGR of 7.5 % during the forecast period. The Accessories & Consumables market is expected to witness a CAGR of 8.1% during (2026 - 2033). The Software market is expected to witness a CAGR of 8.7% during (2026 - 2033).
Devices represent the leading product category, supported by continued adoption of portable, handheld, and desktop spirometry systems for clinical and remote respiratory assessment. Accessories & Consumables are supported by recurring demand for mouthpieces, bacterial and viral filters, tubing, sensors, calibration tools, and other components required for hygiene and reliable testing. Software is gaining importance as spirometry becomes increasingly connected to electronic health records, automated interpretation tools, cloud-based data management, reporting platforms, and remote patient-monitoring systems.
Based on Application, the market is segmented into Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Other Application. The Chronic Obstructive Pulmonary Disorder (COPD) market dominated the Global Spirometer Market by Application in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 726.8 million by 2033, growing at a CAGR of 7.3 % during the forecast period. The Asthma market is expected to witness a CAGR of 8.3% during (2026 - 2033). Additionally, The Other Application market is expected to witness highest CAGR of 8.5% during (2026 - 2033).
COPD represents the leading application area as spirometry is essential for detecting persistent airflow limitation, assessing disease severity, monitoring progression, and evaluating treatment outcomes. Asthma remains a major application as pulmonary function testing helps clinicians evaluate variable airflow obstruction, monitor respiratory performance, and support long-term disease control. Other Application includes occupational health assessments, preoperative evaluation, respiratory screening, clinical research, and monitoring of other pulmonary conditions.
Based on End User, the market is segmented into Hospitals, Physician & Clinics, Diagnostic Centers, Homecare Settings, and Other Facilities. The Hospitals market dominated the Global Spirometer Market by End User in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 465.3 million by 2033, growing at a CAGR of 7 % during the forecast period. The Physician & Clinics market is expected to witness a CAGR of 7.6% during (2026 - 2033). Additionally, The Diagnostic Centers market is expected to witness highest CAGR of 8.2% during (2026 - 2033).
Hospitals lead the market due to substantial patient volumes, established pulmonary departments, comprehensive diagnostic infrastructure, and routine respiratory function testing. Physician & Clinics are gaining demand as compact and portable spirometers support outpatient pulmonary assessment and primary care screening. Diagnostic Centers remain important due to specialized respiratory testing services, while Homecare Settings are expanding through connected and portable devices that support remote monitoring and long-term chronic disease management. Other Facilities include rehabilitation centers, occupational health facilities, research institutions, and specialized care environments.
Free Valuable Insights: Spirometer Market Size to reach $1511.6 Million by 2033
Region-wise, the Spirometer Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2025, the North America led the spirometer market and is predicted to stay dominant till 2033, by gathering a market value of USD 565.1 million by 2033, expanding at a CAGR of 7.6%. The Europe market is predicted to witness a CAGR of 7.2% during the forecast period. Moreover, the APAC region is predicted to grow at a CAGR of 7.6% during 2026-2033.
North America dominated the market because of high pulmonary function testing volumes, respiratory care infrastructure, strong adoption of advanced diagnostic systems, and favorable access to specialized healthcare services. Europe is driven by standardized pulmonary function testing, respiratory disease management programs, and strong clinical infrastructure. APAC is growing because of enhancing healthcare expenditure, rising respiratory disease awareness, growing access to pulmonary testing technologies, and diagnostic infrastructure development. LAMEA is witnessing expansion through healthcare infrastructure development and adoption of digital and portable spirometry systems.
| Report Attribute | Details |
|---|---|
| Market size value in 2026 | USD 889.6 million |
| Market size forecast in 2033 | USD 1511.6 million |
| Base Year | 2025 |
| Historical Period | 2022 to 2024 |
| Forecast Period | 2026 to 2033 |
| Revenue Growth Rate | CAGR of 7.9% from 2026 to 2033 |
| Number of Pages | 676 |
| Tables | 750 |
| Report Coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Market Share Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Product Life Cycle Analysis, Value Chain Analysis, Market Consolidation Analysis, Key Customer Criteria, Pandemic Impact Analysis, and Winning Imperatives |
| Segments Covered | Type, Product Type, Application, End User, Region |
| Country Scope |
|
| Companies Included | Vyaire Medical, Inc., NDD Medical Technologies, Medical International Research S.p.A., Vitalograph Ltd., SCHILLER AG, MGC Diagnostics Corporation, COSMED S.r.l., Geratherm Respiratory GmbH, Ganshorn Medizin Electronic GmbH, and Fukuda Sangyo Co., Ltd. |
By Type
By Product Type
By Application
By End User
By Geography
Expected to reach USD 1511.6 million by 2033, growing at 7.9% CAGR during the forecast period (2026-2033).
The market is growing at 7.9% CAGR during the forecast period (2026-2033).
Vyaire Medical, Inc., NDD Medical Technologies, Medical International Research S.p.A., and Vitalograph Ltd. are key players.
Increasing prevalence of respiratory diseases and integration of digital health technologies are key growth drivers.
North America is expected to dominate due to advanced healthcare infrastructure and high adoption of spirometers.
The Global Spirometer Market size is expected to reach USD 1511.6 million by 2033.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 